P10.27.B PRECLINICAL MODELLING AND DRUG SENSITIVITY DISCOVERY USING PATIENT- AND PDX-DERIVED TUMOROIDS OF HIGH RISK MEDULLOBLASTOMA

C Meulenbroeks; P Stathi; C Giebel; M van de Wetering; B Schwalm; N Mack; N Geisemeyer; S L A Plasschaert; S M Pfister; M E G Kranendonk; E W Hoving; J Bunt; M Kool

doi:10.1093/neuonc/noaf193.338

P10.27.B PRECLINICAL MODELLING AND DRUG SENSITIVITY DISCOVERY USING PATIENT- AND PDX-DERIVED TUMOROIDS OF HIGH RISK MEDULLOBLASTOMA

C Meulenbroeks
, P Stathi
, C Giebel
, M van de Wetering
, B Schwalm
, N Mack
, N Geisemeyer
, S L A Plasschaert
, S M Pfister
, M E G Kranendonk
, E W Hoving
, J Bunt
, M Kool

Research output: Contribution to journal › Article

Original language	Dutch
Pages (from-to)	iii102-iii102
Journal	Neuro-Oncology
Volume	27
Issue number	Supplement_3
DOIs	https://doi.org/10.1093/neuonc/noaf193.338
Publication status	Published - Mar 2025

Access to Document

10.1093/neuonc/noaf193.338

Cite this

Meulenbroeks, C., Stathi, P., Giebel, C., van de Wetering, M., Schwalm, B., Mack, N., Geisemeyer, N., Plasschaert, S. L. A., Pfister, S. M., Kranendonk, M. E. G., Hoving, E. W., Bunt, J., & Kool, M. (2025). P10.27.B PRECLINICAL MODELLING AND DRUG SENSITIVITY DISCOVERY USING PATIENT- AND PDX-DERIVED TUMOROIDS OF HIGH RISK MEDULLOBLASTOMA. Neuro-Oncology, 27(Supplement_3), iii102-iii102. https://doi.org/10.1093/neuonc/noaf193.338

@article{39ccd089afbe484c8d961b5b8b199df1,

title = "P10.27.B PRECLINICAL MODELLING AND DRUG SENSITIVITY DISCOVERY USING PATIENT- AND PDX-DERIVED TUMOROIDS OF HIGH RISK MEDULLOBLASTOMA",

author = "C Meulenbroeks and P Stathi and C Giebel and \{van de Wetering\}, M and B Schwalm and N Mack and N Geisemeyer and Plasschaert, \{S L A\} and Pfister, \{S M\} and Kranendonk, \{M E G\} and Hoving, \{E W\} and J Bunt and M Kool",

year = "2025",

month = mar,

doi = "10.1093/neuonc/noaf193.338",

language = "Nederlands",

volume = "27",

pages = "iii102--iii102",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "Supplement\_3",

}

Meulenbroeks, C, Stathi, P, Giebel, C, van de Wetering, M, Schwalm, B, Mack, N, Geisemeyer, N, Plasschaert, SLA, Pfister, SM, Kranendonk, MEG, Hoving, EW , Bunt, J & Kool, M 2025, 'P10.27.B PRECLINICAL MODELLING AND DRUG SENSITIVITY DISCOVERY USING PATIENT- AND PDX-DERIVED TUMOROIDS OF HIGH RISK MEDULLOBLASTOMA', Neuro-Oncology, vol. 27, no. Supplement_3, pp. iii102-iii102. https://doi.org/10.1093/neuonc/noaf193.338

TY - JOUR

T1 - P10.27.B PRECLINICAL MODELLING AND DRUG SENSITIVITY DISCOVERY USING PATIENT- AND PDX-DERIVED TUMOROIDS OF HIGH RISK MEDULLOBLASTOMA

AU - Meulenbroeks, C

AU - Stathi, P

AU - Giebel, C

AU - van de Wetering, M

AU - Schwalm, B

AU - Mack, N

AU - Geisemeyer, N

AU - Plasschaert, S L A

AU - Pfister, S M

AU - Kranendonk, M E G

AU - Hoving, E W

AU - Bunt, J

AU - Kool, M

PY - 2025/3

Y1 - 2025/3

UR - https://www.mendeley.com/catalogue/570804d0-40cb-3c06-ae7e-d5b4c42fb097/

U2 - 10.1093/neuonc/noaf193.338

DO - 10.1093/neuonc/noaf193.338

M3 - Artikel

SN - 1522-8517

VL - 27

SP - iii102-iii102

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - Supplement_3

ER -